Inicio>>Signaling Pathways>> PROTAC>>Lipoamido-PEG3-OH

Lipoamido-PEG3-OH

Catalog No.GC67162

Lipoamido-PEG3-OH es un conector PROTAC basado en PEG que se puede utilizar en la síntesis de PROTAC. Lipoamido-PEG3-OH (compuesto TA-TEG-G2CN) se puede utilizar en la formación de una plataforma de administración de fármacos basada en nanopartículas de oro dendronizadas (AuNP) altamente estable.

Products are for research use only. Not for human use. We do not sell to patients.

Lipoamido-PEG3-OH Chemical Structure

Cas No.: 1342764-64-0

Tamaño Precio Disponibilidad Cantidad
1g
3.468,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lipoamido-PEG3-OH is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Lipoamido-PEG3-OH (compound TA-TEG-G2CN) can be used in the formation of a highly stable, dendronized gold nanoparticle (AuNP)-based drug delivery platform[1].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein.
PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

[1]. Saha Ray A,et al. Set of Highly Stable Amine- and Carboxylate-Terminated Dendronized Au Nanoparticles with Dense Coating and Nontoxic Mixed-Dendronized Form.Langmuir. 2019 Mar 5;35(9):3391-3403.

Reseñas

Review for Lipoamido-PEG3-OH

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lipoamido-PEG3-OH

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.